Statistics for A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors

Total visits

views
A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors 0

Total visits per month

views
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0

File Visits

views
java.util.UUID:9daa55e9-6d83-4e85-b4f7-1260100acc1c 13
Fountzilas2021Phase-AAM.pdf 8
java.util.UUID:5f834c96-70d7-439c-a2fc-b2e41077f86c 6
java.util.UUID:7a0d83d2-adce-48af-8e03-35a99b07dbca 1